Diabetes management has witnessed a significant transformation with the introduction of Rybelsus, an innovative medication that brings a remarkable advantage over traditional treatments. As a glucagon-like peptide-1 (GLP-1) receptor agonist, Rybelsus offers a unique oral delivery method that simplifies adherence for patients who prefer not to use injections. This convenience…